linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Glaxosmithkline Pharmaceuticals Ltd.
 
Industry : Pharmaceuticals & Drugs House : Glaxosmithkline - MNC
BSE Code 500660
ISIN Demat INE159A01016
Book Value 116.88
NSE Code GLAXO
Dividend Yield % 2.25
Market Cap 405727.45
P/E 40.69
EPS 58.85
Face Value 10  
 
Incorporation Year 13-11 1924  
Registered Office Gsk House, Dr. Annie Besant Road,Worli,, Mumbai,
Maharashtra-400030 .
ISINNO INE159A01016  
Phone 022-24959595  
E-mail askus@gsk.com / in.investorquery@gsk.com
URL www.gsk-india.com
Industry Pharmaceuticals & Drugs  
Chairman Renu Sud Karnad  
Managing Director Bhushan Akshikar  
Company Secretary Ajay Nadkarni  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.